DS

Deepika Sharma

Director Director DIN 07685811
DIN 07685811 First appointment Dec 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2016
Shareholding value •••• Premium profile

About Deepika Sharma

Data last updated:

Deepika Sharma was a Director at Volus Pharma Private Limited (2017–2021) and Director at Hauz Pharma Private Limited (2016–2019). The companies operate in Pharma.

DIN 07685811
Primary Designation Director
Industry Pharma
First Appointment 27 Dec 2016

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Volus Pharma Private Limited U24100HR2017PTC067442
Director06 Feb 20172017₹3.66 Cr (FY 2025)Active
Hauz Pharma Private Limited U24232CH2009PTC031626
Director27 Dec 20162009₹30.46 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Volus Pharma Private Limited
Hauz Pharma Private Limited
Premium access

Shareholding and investment profile for Deepika Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepika Sharma

Deepika Sharma was first appointed on 27 Dec 2016 as Director at Hauz Pharma Private Limited. The most recent appointment on record is 06 Feb 2017 at Volus Pharma Private Limited.

Deepika Sharma held 2 earlier board appointments: Volus Pharma Private Limited (Director, 06 Feb 2017 to 01 Jun 2021); Hauz Pharma Private Limited (Director, 27 Dec 2016 to 29 Jun 2019).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available